<!DOCTYPE html>
<html>
<head>
<title>Monopar Therapeutics Inc. Quarterly report pursuant to Section 13 or 15(d)</title>
<link href="https://ir.monopartx.com/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
<script type="text/javascript" src="https://ir.monopartx.com/javascripts/ir.js"></script>
<link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.min.js"></script>
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.js"></script>
</head>
<body>
<style>
body {
font-family: Arial, Helvetica, sans-serif;
font-size: 12px;
color: #454545;
}
</style>
<div class="xbrl-content">
    <h3>Quarterly report pursuant to Section 13 or 15(d)</h3>
    <div id="xbrl-menu-top">
        <div class="navigation">
            <ul class="xbrl-sf-menu">
                
                    <li>
                        <a class="menu-item " href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/89">Cover</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/89">Document and Entity Information</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/90">Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/90">Balance Sheet</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/91">Balance Sheet (Parenthetical)</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/92">Statements of Operations</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/93">Statement of Cash Flows</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/94">Notes to Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/94">1. Nature of Business and Liquidity</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/95">2. Significant Accounting Policies</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/96">3. Capital Stock</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/97">4. Stock Option Plan</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/98">5. Development and Collaboration Agreements</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/99">6. Related Party Transactions</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/100">7. Commitments and Contingencies</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/101">Accounting Policies</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/101">2. Significant Accounting Policies (Policies)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/102">Notes Tables</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/102">2. Significant Accounting Policies (Tables)</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/103">4. Stock Option Plan (Tables)</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/104">7. Commitments and Contingencies (Tables)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item current" href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/105">Notes Details</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/105">1. Nature of Business and Liquidity (Details Narrative)</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/106">2. Significant Accounting Policies (Details)</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/107">2. Significant Accounting Policies (Details Narrative)</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/108">3. Capital Stock (Details Narrative)</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/109">4. Stock Option Plan (Details)</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/110">4. Stock Option Plan (Details 1)</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/111">4. Stock Option Plan (Details Narrative)</a></li>
                                                            <li><a href="https://ir.monopartx.com/quarterly-reports/xbrl_doc_only/112">7. Commitments and Contingencies (Details)</a></li>
                                                    </ul>
                    </li>
                            </ul>
        </div>
    </div>
    <div class="spr-xbrl-document">
        <h4>4. Stock Option Plan (Details)</h4>
                <div style="clear:both;"></div>
    </div>
</div>
</body>
</html>